| 國立成功大學 |
2014-12 |
Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study
|
Chen, Chi-An; Lin, Hao; Weng, Chia-Sui; Wen, Kuo-Chang; Lu, Chien-Hsing; Chou, Hung-Hsueh; Huang, Yu-Fang; Kang, Chieh-Yi; Ho, Chih-Ming; Yu, Mu-Hsien; Chou, Cheng-Yang |
| 臺大學術典藏 |
2018-09-10T15:02:48Z |
Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study
|
Chen, C.-A. and Lin, H. and Weng, C.-S. and Wen, K.-C. and Lu, C.-H. and Chou, H.-H. and Huang, Y.-F. and Kang, C.-Y. and Ho, C.-M. and Yu, M.-H. and Chou, C.-Y.; CHI-AN CHEN |
| 臺大學術典藏 |
2014 |
Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study
|
Lin H.; Weng C.-S.; Wen K.-C.; Lu C.-H.; Chou H.-H.; Huang Y.-F.; Kang C.-Y.; Ho C.-M.; Yu M.-H.; Chou C.-Y.; CHI-AN CHEN |
| 國立成功大學 |
2002-04 |
Outcome of acid ingestion related aspiration pneumonia
|
Tseng, Yau-Lin; Wu, Ming-Ho; Lin, Mu-Yen; Lai, Wu-Wei |
| 國立成功大學 |
2011 |
Outcome of Acute Ischemic Stroke in Very Elderly Patients: Is Intravenous Thrombolysis Beneficial?
|
Sung, Pi-Shan; Chen, Chih-Hung; Hsieh, Han-Chieh; Fang, Chen-Wen; Hsieh, Cheng-Yang; Sun, Yuan-Ting; Hwang, Wen-Juh |
| 臺大學術典藏 |
2020-09-29T16:41:33Z |
Outcome of acute leukemia patients with central nervous system (CNS) involvement treated with total body or CNS irradiation before transplantation
|
Kuo, Wen-Han; Chen, Yu-Hsuan; Kuo, Sung-Hsin; Tang, Jih-Luh; Liao, Xiu-Wen; Tsai, Cheng-Hong |
| 臺大學術典藏 |
2018 |
Outcome of acute leukemia patients with central nervous system (CNS) involvement treated with total body or CNS irradiation before transplantation
|
Liao, Xiu-Wen; Kuo, Sung-Hsin; Tang, Jih-Luh; Kuo, Wen-Han; CHENG-HONG TSAI; Chen, Yu-Hsuan |
| 臺大學術典藏 |
2022-08-19T00:21:08Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; CHIUN HSU; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 臺大學術典藏 |
2020-04-28T07:25:30Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.; CHIH-HUNG HSU; Yu C.-J.; Chang Y.-C.; Hsu C.; Yang C.-H.;Yang P.-C.;Cheng A.-L.;Lin C.-C.;CHIH-HUNG HSU;Yu C.-J.;Chang Y.-C.;Hsu C.;Lin Z.-Z.; Lin Z.-Z. |
| 臺大學術典藏 |
2020-05-25T07:35:32Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Yang C.-H.;Yang P.-C;Cheng A.-L;Chia-Chi Lin;Hsu C.-H;Yu C.-J;Chang Y.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C; Chang Y.-C; Yu C.-J; Hsu C.-H; Chia-Chi Lin; Cheng A.-L; Yang P.-C; Yang C.-H. |
| 臺大學術典藏 |
2008 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
CHIH-HSIN YANG; Yang P.-C; Cheng A.-L; Lin C.-C; Hsu C.-H; Yu C.-J; Chang Y.-C; Chih-Hsin Yang;Yang P.-C;Cheng A.-L;Lin C.-C;Hsu C.-H;Yu C.-J;Chang Y.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C |
| 臺大學術典藏 |
2020-04-10T12:51:23Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Yang C.-H.; Yang P.-C.; Cheng A.-L.; Lin C.-C.; Hsu C.-H.; Yu C.-J.; Chang Y.-C.; Chiun Hsu; Lin Z.-Z. |
| 臺大學術典藏 |
2020-08-12T06:35:40Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.;Hsu C.;Chang Y.-C.;Chong-Jen Yu;Hsu C.-H.;Lin C.-C.;Cheng A.-L.;Yang P.-C.;Yang C.-H.; Lin Z.-Z.; Hsu C.; Chang Y.-C.; CHONG-JEN YU; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2021-03-19T06:57:53Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; YEUN-CHUNG CHANG; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2021-09-01T01:54:29Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; ANN-LII CHENG; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2021-08-11T03:46:53Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
ZHONG-ZHE LIN; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2020-12-02T02:34:36Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; PAN-CHYR YANG; Yang C.-H. |
| 臺大學術典藏 |
2022-06-10T06:11:16Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
ZHONG-ZHE LIN; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2022-06-27T07:06:22Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; Chang Y.-C.; CHONG-JEN YU; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2022-09-15T01:09:52Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Chia-Chi Lin; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 中國醫藥大學 |
2007-06 |
Outcome of and prognostic factors for decompressive hemicraniectomy in malignant middle cerebral artery infarction.
|
陳春忠(CGUN-CHUNG CHEN); 周德陽(Der-Yang Cho); 蔡淑秋(shu-Chiu Tsi) |
| 中國醫藥大學 |
2010-04 |
Outcome of atrial fibrillation among patients with end-stage renal disease
|
周哲毅(Che-Yi Chou); 郭慧亮(Huey-Liang kuo); 王舒民(Shu-Ming Wang); 劉炯勳(Jiung-Hsiun Liu); 林信宏(Hsin-Hung Lin); 劉耀隆(Yao-Lung Liu)*; 黃秋錦(Chiu-Ching Huang) |
| 臺大學術典藏 |
2020-07-17T03:45:58Z |
Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer
|
Wan-Yu Chen;Chen Tc;Lai Sf;Liang Th;Huang Bs;Wang Cw; WAN-YU CHEN; Chen TC; Lai SF; Liang TH; Huang BS; Wang CW |
| 臺大學術典藏 |
2021-04-28T06:58:16Z |
Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer
|
Chen W.-Y.;Chen T.-C.;Lai S.-F.;Liang T.H.-K.;Huang B.-S.;Chun-Wei Wang; Chen W.-Y.; Chen T.-C.; Lai S.-F.; Liang T.H.-K.; Huang B.-S.; CHUN-WEI WANG |
